BDX Stock Price Today (November 2026) — Becton, Dickinson and Company Analysis & Key Metrics 2026-11-18
Becton, Dickinson and Company (BDX) is trading at $216.08, up 0.31% today (as of November 2026).The stock is trading above its 50-day and 200-day moving averages.
- According to consensus analyst estimates, the 1-year price target is $226.14 (4.7% upside).
- Volatility is moderate (26.37% annualized), between 25% and 40%.
- From the latest financial filings: Revenue fell 10.50% in the latest quarter compared with the same quarter a year earlier. Debt is 0.66 times shareholders' equity.
BDX Stock Analysis: Key Metrics & Valuation (November 2026)
Key figures from the latest data
Becton, Dickinson and Company - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $74.47B
P/E Ratio
Forward P/E: 14.95
Revenue Growth
Latest quarter vs year ago
Analyst Target
+4.7% upside potential
Key Investor Questions About BDX
What the latest data shows
BDX is trading above its 50-day and 200-day moving averages, and its RSI of 70.4 is in the overbought zone.
- Technicals: Overbought (RSI 70.40) (Uptrend: above 50- and 200-day averages)
- Fundamentals: Revenue -10.5%, debt/equity 0.66x
Revenue fell 10.50% in the latest quarter compared with the same quarter a year earlier.
- Total debt is $16.34B (0.66 times equity).
- 30-day volatility is 26.37% annualized, which counts as moderate (between 25% and 40%).
52-Week Trading Range
Over the past year, BDX stock traded between $139.29 and $220.36 and currently trades near the high end of that range.
Volatility & Risk Profile
30-day volatility is 26.37% annualized, which counts as moderate (between 25% and 40%). Beta 0.34: the stock has moved much less than the market.
Institutional & Insider Ownership
Institutions own 98.20% of the shares, and short interest is 3.39% of the float.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
BD Marks 85 Years of Essential Medical Device Manufacturing in Glen Falls, NY
BD Named to TIME's 2027 List of America's Top Manufacturers
Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?
Accelerating Organic Growth Drives Becton, Dickinson and Company’s (BDX) Outperformance
BD to Host Investor Day on December 10, 2026
Latest TickZen Insights
All insights →No TickZen article on BDX yet. Our newest analysis:
Explore More Analysis for BDX
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
No upcoming report date yet
Frequently Asked Questions
Common investor questions about Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) is currently trading at $216.08. The RSI (14-day) is 70.4, at or above 70, the level usually called overbought. Wall Street analysts have a consensus "Buy" recommendation. The mean analyst price target of $226.14 implies 4.7% upside from current levels. 30-day volatility is 26.37% annualized, which counts as moderate (between 25% and 40%).
Based on current valuation metrics for Becton, Dickinson and Company (BDX): The trailing P/E ratio is 42.70. The forward P/E is 14.95, lower than the trailing P/E, suggesting analysts expect earnings improvement. Price-to-Book is 2.39. Price-to-Sales is 3.03. Different industries trade at different multiples, so these figures are most useful next to Medical Instruments & Supplies peers.
Based on 14 analysts covering BDX, the consensus price target is $226.14. This represents a 4.7% upside from the current price of $216.08. The range spans from a low target of $195.00 to a high target of $242.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "Buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Becton, Dickinson and Company (BDX) pays a dividend with a current yield of approximately 1.96%. The annualized dividend rate is $4.24 per share. The payout ratio is 72.5%, which is moderate and suggests adequate earnings coverage for the dividend. The next ex-dividend date is Dec 10, 2026.
Key risks for Becton, Dickinson and Company (BDX) shown in the latest data: 1. Moderate volatility (26.4% annualized, between 25% and 40%). 2. Declining revenue (-10.5% in the latest quarter compared with a year earlier). 3. Moves in the broader stock market (Beta 0.34: the stock has moved much less than the market).
Here is Becton, Dickinson and Company's (BDX) current debt and financial health profile: Total debt stands at $16.34B. The debt-to-equity ratio is 0.66x, which is moderate and generally manageable for most companies. The current ratio is 0.87, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.37. The company holds $733.00M in cash and equivalents. Free cash flow is positive at $2.69B, providing a cushion for debt servicing and shareholder returns.